<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genomic Health, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genomic Health, Inc.

    Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      8071
    • NIN CODE
      ####
    • LEADERSHIP
      Kimberly Popovits
    • FOUNDED
      2000
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    GuruMD Virtual Med, Inc

    GuruMD Virtual Med, Inc

    GuruMD directs patients away from costly emergency rooms and urgent cares by provi...

    GuruMD directs patients away from costly emerge...

    Amount Raised:    $70,636.68
    Fundraising Status:    EC
    Filing Type:    CF
    Lab Sensor Solutions, Inc.

    Lab Sensor Solutions, Inc.

    Lab Sensor Solutions’ mission is to improve lives through the use of real-time s...

    Lab Sensor Solutions’ mission is to improve l...

    Fundraising Status:    EC
    Filing Type:    CF
    Akebia Therapeutics, Inc.

    Akebia Therapeutics, Inc.

    We are a fully integrated biopharmaceutical company focused on the development and...

    We are a fully integrated biopharmaceutical com...

    Filing Type:    PU
    Oxford Immunotec Global PLC

    Oxford Immunotec Global PLC

    We are a global, high-growth diagnostics company committed to improving patient ca...

    We are a global, high-growth diagnostics compan...

    Filing Type:    PU
    Audentes Therapeutics, Inc.

    Audentes Therapeutics, Inc.

    Audentes Therapeutics is a leading AAV-based genetic medicines company focused on ...

    Audentes Therapeutics is a leading AAV-based ge...

    Filing Type:    PU
    Intellia Therapeutics, Inc.

    Intellia Therapeutics, Inc.

    Intellia Therapeutics is a leading genome editing company focused on developing cu...

    Intellia Therapeutics is a leading genome editi...

    Filing Type:    PU
    Delee Corp

    Delee Corp

    At Delee, we aim to radically change the way cancer is detected, monitored and tre...

    At Delee, we aim to radically change the way ca...

    Fundraising Status:    EC
    Filing Type:    CF
    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics is focused on developing and commercializing molecular diagn...

    Interpace Diagnostics is focused on developing ...

    Filing Type:    PU
    Ourotech, Inc.

    Ourotech, Inc.

    A patient that is diagnosed with cancer today will have a genetic screen on their ...

    A patient that is diagnosed with cancer today w...

    Fundraising Status:    SD
    Filing Type:    CF
    Infinity Pharmaceuticals, Inc.

    Infinity Pharmaceuticals, Inc.

    Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicate...

    Infinity Pharmaceuticals, Inc. is an innovative...

    Filing Type:    PU
    Kitov Pharma Ltd.

    Kitov Pharma Ltd.

    Kitov Pharma is an innovative biopharmaceutical drug development company. Leveragi...

    Kitov Pharma is an innovative biopharmaceutical...

    Filing Type:    PU
    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-base...

    Takeda Pharmaceutical Company Limited (TSE:4502...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.